Myriad Genetics | 10-Q: Q3 2024 Earnings Report
Myriad Genetics | 10-Q: Q2 2024 Earnings Report
Myriad Genetics | 8-K: Myriad Genetics Reports Strong Second Quarter 2024 Financial Results, including 15% Revenue Growth Year-Over-Year; Raises 2024 Financial Guidance and Long-Term Revenue Growth Target to 12%
Myriad Genetics | 10-Q: Q1 2024 Earnings Report
Myriad Genetics | 8-K: Myriad Genetics Reports Strong First Quarter 2024 Financial Results; Achieves 12% Revenue Growth Year-Over-Year; Significantly Improved Year-Over-Year Net Loss and Generated Positive Adjusted EBITDA
Myriad Genetics | 10-K: FY2023 Annual Report
Myriad Genetics | 10-Q: Q3 2023 Earnings Report
Myriad Genetics | 8-K: Myriad Genetics Reports Third Quarter 2023 Financial Results; Generates Double-Digit Revenue Growth ; Raises 20 23 Revenue Guidance andIntroduces 2024 Revenue Guidance
Myriad Genetics | 10-Q: Q2 2023 Earnings Report
Myriad Genetics | 8-K: Myriad Genetics Reports Second Quarter 2023 Financial Results and Reaffirms 2023 Revenue and Adjusted EPS Guidance; Generates the Fourth Consecutive Quarter of Double-Digit Year-Over-Year Testing Volume Growth
Myriad Genetics | 10-Q: Q1 2023 Earnings Report
Myriad Genetics | 8-K: Myriad Genetics Reports First Quarter 2023 Financial Results; Achieves 10% Revenue Growth Year-Over-Year, the Second Consecutive Quarter of Double-Digit Year-Over-Year Revenue Growth; Raises Mid-Point of 2023 Revenue Guidance Range
Myriad Genetics | 10-K: FY2022 Annual Report
Myriad Genetics | 8-K: Myriad Genetics Reports Fourth Quarter Financial Results; Fourth Quarter Revenue of $177.8 Million Grew 11% Year-Over-Year Driven by 16% Growth in Hereditary Cancer Volumes and 23% Growth in GeneSight ® Volumes
Myriad Genetics | 10-Q: Q3 2022 Earnings Report
Myriad Genetics | 8-K: Myriad Genetics Reports Third Quarter Financial Results
Myriad Genetics | 10-Q: Q2 2022 Earnings Report
Myriad Genetics | 8-K: Myriad Genetics Reports Second Quarter Financial Results
Myriad Genetics | 10-Q: Q1 2022 Earnings Report
Myriad Genetics | 10-K: FY2021 Annual Report
No Data
No Data